TGR5 agonist (Shaperon)

N/A

Report date: 2025/06/11 11:17:03
NME

Base Information

Drug NameTGR5 agonist (Shaperon)
Drug Alias Nameinflammasome inhibitors (Shaperon)HY-304HY-307
ClassificationSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsImmunomodulatorsG-protein coupled bile acid receptor 1 agonists +[4] 
TargetsG-protein coupled bile acid receptor 1NACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShaperon
China Registration ClassN/A

Develop Information

Active CompaniesShaperon
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A